Clinical Trial Update: Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Pentasa (mesalamine) once daily for maintenance of remission in Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED